These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 12019167)

  • 41. T-cell epitope processing (the epitope flanking regions matter).
    Martinez AN; Tenzer S; Schild H
    Methods Mol Biol; 2009; 524():407-15. PubMed ID: 19377961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA-A*0201-restricted T cells.
    Harada M; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
    Cancer Res; 2001 Feb; 61(3):1089-94. PubMed ID: 11221837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An antigenic peptide produced by peptide splicing in the proteasome.
    Vigneron N; Stroobant V; Chapiro J; Ooms A; Degiovanni G; Morel S; van der Bruggen P; Boon T; Van den Eynde BJ
    Science; 2004 Apr; 304(5670):587-90. PubMed ID: 15001714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of the processing of seven human tumor antigens by intermediate proteasomes.
    Guillaume B; Stroobant V; Bousquet-Dubouch MP; Colau D; Chapiro J; Parmentier N; Dalet A; Van den Eynde BJ
    J Immunol; 2012 Oct; 189(7):3538-47. PubMed ID: 22925930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical analysis of proteasomes from mouse microglia: induction of immunoproteasomes by interferon-gamma and lipopolysaccharide.
    Stohwasser R; Giesebrecht J; Kraft R; Müller EC; Häusler KG; Kettenmann H; Hanisch UK; Kloetzel PM
    Glia; 2000 Feb; 29(4):355-65. PubMed ID: 10652445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells.
    Visseren MJ; van Elsas A; van der Voort EI; Ressing ME; Kast WM; Schrier PI; Melief CJ
    J Immunol; 1995 Apr; 154(8):3991-8. PubMed ID: 7706738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphorylation of the proteasome activator PA28 is required for proteasome activation.
    Li N; Lerea KM; Etlinger JD
    Biochem Biophys Res Commun; 1996 Aug; 225(3):855-60. PubMed ID: 8780702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural plasticity of the proteasome and its function in antigen processing.
    Groettrup M; van den Broek M; Schwarz K; Macagno A; Khan S; de Giuli R; Schmidtke G
    Crit Rev Immunol; 2001; 21(4):339-58. PubMed ID: 11922078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells.
    Sijts AJ; Standera S; Toes RE; Ruppert T; Beekman NJ; van Veelen PA; Ossendorp FA; Melief CJ; Kloetzel PM
    J Immunol; 2000 May; 164(9):4500-6. PubMed ID: 10779750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modeling the in vitro 20S proteasome activity: the effect of PA28-alphabeta and of the sequence and length of polypeptides on the degradation kinetics.
    Mishto M; Luciani F; Holzhütter HG; Bellavista E; Santoro A; Textoris-Taube K; Franceschi C; Kloetzel PM; Zaikin A
    J Mol Biol; 2008 Apr; 377(5):1607-17. PubMed ID: 18336834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteasome inhibitors reconstitute the presentation of cytotoxic T-cell epitopes in Epstein-Barr virus-associated tumors.
    Gavioli R; Vertuani S; Masucci MG
    Int J Cancer; 2002 Oct; 101(6):532-8. PubMed ID: 12237893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impaired immunoproteasome assembly and immune responses in PA28-/- mice.
    Preckel T; Fung-Leung WP; Cai Z; Vitiello A; Salter-Cid L; Winqvist O; Wolfe TG; Von Herrath M; Angulo A; Ghazal P; Lee JD; Fourie AM; Wu Y; Pang J; Ngo K; Peterson PA; Früh K; Yang Y
    Science; 1999 Dec; 286(5447):2162-5. PubMed ID: 10591649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Final antigenic Melan-A peptides produced directly by the proteasomes are preferentially selected for presentation by HLA-A*0201 in melanoma cells.
    Chapatte L; Servis C; Valmori D; Burlet-Schiltz O; Dayer J; Monsarrat B; Romero P; Lévy F
    J Immunol; 2004 Nov; 173(10):6033-40. PubMed ID: 15528338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentation.
    Basler M; Lauer C; Moebius J; Weber R; Przybylski M; Kisselev AF; Tsu C; Groettrup M
    J Immunol; 2012 Aug; 189(4):1868-77. PubMed ID: 22772448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Melanoma patients respond to a new HLA-A*01-presented antigenic ligand derived from a multi-epitope region of melanoma antigen TRP-2.
    Paschen A; Jing W; Drexler I; Klemm M; Song M; Müller-Berghaus J; Nguyen XD; Osen W; Stevanovic S; Sutter G; Schadendorf D
    Int J Cancer; 2005 Oct; 116(6):944-8. PubMed ID: 15856458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I-binding peptides in vivo.
    de Graaf N; van Helden MJ; Textoris-Taube K; Chiba T; Topham DJ; Kloetzel PM; Zaiss DM; Sijts AJ
    Eur J Immunol; 2011 Apr; 41(4):926-35. PubMed ID: 21360704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.
    Sewell AK; Price DA; Teisserenc H; Booth BL; Gileadi U; Flavin FM; Trowsdale J; Phillips RE; Cerundolo V
    J Immunol; 1999 Jun; 162(12):7075-9. PubMed ID: 10358150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage.
    Lupetti R; Pisarra P; Verrecchia A; Farina C; Nicolini G; Anichini A; Bordignon C; Sensi M; Parmiani G; Traversari C
    J Exp Med; 1998 Sep; 188(6):1005-16. PubMed ID: 9743519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells.
    Ossendorp F; Fu N; Camps M; Granucci F; Gobin SJ; van den Elsen PJ; Schuurhuis D; Adema GJ; Lipford GB; Chiba T; Sijts A; Kloetzel PM; Ricciardi-Castagnoli P; Melief CJ
    J Immunol; 2005 Jun; 174(12):7815-22. PubMed ID: 15944286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allele-selective effect of PA28 in MHC class I antigen processing.
    Yamano T; Sugahara H; Mizukami S; Murata S; Chiba T; Tanaka K; Yui K; Udono H
    J Immunol; 2008 Aug; 181(3):1655-64. PubMed ID: 18641301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.